Results 31 to 40 of about 640 (208)
Anti-inflammatory and antinociceptive activities of indole–imidazolidine derivatives [PDF]
Non-steroidal anti-inflammatory drugs (NSAIDs) represent a group of approximately 50 different medicines that are widely prescribed for the management of inflammation and that exhibit variable anti-inflammatory, anti-pyretic and analgesic activities ...
Cavalcanti Colaço, Nathália+8 more
core +1 more source
This review evaluates the effects of mass deworming for soil‐transmitted helminths on growth, educational achievement, cognition, school attendance, quality of life and adverse effects in children in endemic helminth areas. Mass deworming for soil‐transmitted helminths probably has little to no effect on weight, height, school attendance, cognition ...
Vivian A. Welch+14 more
wiley +1 more source
Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents
The susceptibility of four isolates of Schistosoma mansoni (BH, MAP, MPR-1 and K) to four multiple doses of anti-schistosomal agents (hycanthone, niridazole, oxamniquire, and praziquantel) were evaluated in infected female Swiss albino mice.
Kristen M. Drescher+5 more
doaj +1 more source
Three distinct syndromes caused by schistosomiasis have been described: cercarial dermatitis or swimmer's itch, acute schistosomiasis or Katayama fever, and chronic schistosomiasis. Complications of acute schistosomiasis have also been reported.
J. R. Lambertucci
doaj +1 more source
Previous studies conducted with the imidazolidinic derivative 3‐benzyl‐5‐(4‐chloro‐arylazo)‐4‐thioxo‐imidazolidin‐2‐one (LPSF‐PT05) show outstanding activity against adult Schistosoma mansoni worms in vitro. In the first phase of this study, S. mansoni‐infected mice were treated, orally, with 100 mg/Kg of the LPSF‐PT05 in three formulations: Tween 80 ...
Andréa Cristina Apolinário da Silva+11 more
wiley +1 more source
Novel Therapeutic and Prevention Approaches for Schistosomiasis: Review
Schistosomiasis is a debilitating disease affecting approximately 600 million people in 74 developing countries, with 800 million, mostly children at risk. To circumvent the threat of having praziquantel (PZQ) as the only drug used for treatment, several
Rashika A.F. El Ridi+1 more
doaj +1 more source
Pseudotumoral form of neuroschistosomiasis: report of three cases
Central nervous system (CSN) involvement in schistosomiasis is an ectopic manifestation with a large variety of clinical forms, including pseudotumoral, which occurs in isolated cases and is rare.
Antonio S. Andrade Filho+8 more
doaj +1 more source
Enhancing schistosomiasis drug discovery approaches with optimized proteasome substrates
Abstract Schistosomiasis, a neglected tropical disease infecting over 200 million people globally, has limited therapeutic options. The 20S proteasome is a validated drug target for many parasitic infections, including those caused by Plasmodium and Leishmania, and we have previously demonstrated antischistosomal activity with inhibitors targeting ...
Elany B. Silva+12 more
wiley +1 more source
Campbell Systematic Reviews, Volume 14, Issue 1, Page 1-22, 2018.
Rehana A Salam+6 more
wiley +1 more source
Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis [PDF]
A random, double-blind, parallel group clinical trial program was carried out to compare praziquantel, a recently developed anti-helmintic drug, and oxamniquine, an already established agent for treating mansoni schistosomiasis.
ANDREWS P.+38 more
core +4 more sources